Viewing Study NCT06762769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-02-01 @ 8:12 PM
Study NCT ID: NCT06762769
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2024-12-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Sponsor: University College, London
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Smouldering Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Isatuximab View
None Iberdomide View
None OBDS View
None Dexamethasone View
None MODIFY View
None Smouldering Myeloma View
None On Body Delivery System View